LG

Lilly Gartia

Active Director Director DIN 09318359
DIN 09318359 First appointment Sep 2021 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2021
Shareholding value •••• Premium profile

About Lilly Gartia

Data last updated:

Lilly Gartia is a Director at Invigor Medical Sciences Private Limited (since 2021). The company operates in Healthcare. Invigor Medical Sciences Private Limited reported revenue of ₹52.5 Lakh (FY 2025).

DIN 09318359
Primary Designation Director
Industry Healthcare
First Appointment 14 Sep 2021
Oldest Company Age 5 yrs
Largest company Invigor Medical Sciences Private Limited · ₹52.5 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director14 Sep 20212021₹52.5 Lakh (FY 2025)Active

Board colleagues of Lilly Gartia

Directorship timeline

Open interactive timeline →
Invigor Medical Sciences Private Limited
Premium access

Shareholding and investment profile for Lilly Gartia

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Lilly Gartia

Lilly Gartia currently holds 1 directorship: Invigor Medical Sciences Private Limited (Director, since 14 Sep 2021, revenue ₹52.5 Lakh (FY 2025)).

Lilly Gartia was first appointed on 14 Sep 2021 as Director at Invigor Medical Sciences Private Limited.

The current boards of Lilly Gartia's companies include Chunnam Vani (Invigor Medical Sciences Private Limited), Pappala Naveen (Invigor Medical Sciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available